PTEN and cancer: Indeed, while Pten undergoes copy number loss as a relatively early event in human prostate carcinogenesis53, 54, mutations of the AR gene have recently been found exclusively in metastatic, castration-resistant human prostate cancer55, indicating that AR plays a more prominent role in later-stage cancer progression.